Coronary Plaque Neovascularization and Hemorrhage. A Potential Target for Plaque Stabilization?

JACC: Cardiovascular Imaging

Volumn 3, Issue 1, 2010, Pages 41-44

  Finn, Aloke V ^a   Jain, Rakesh K ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

angiogenesis; coronary disease; plaque

Indexed keywords

ANGIOGENESIS INHIBITOR; VASCULOTROPIN ANTIBODY;

ARTERY CALCIFICATION; ARTERY INTIMA; ARTERY RUPTURE; ATHEROSCLEROTIC PLAQUE; BLEEDING; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; EDITORIAL; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; HIGH RISK PATIENT; HUMAN; HYPOXEMIA; INFLAMMATORY CELL; MALIGNANT NEOPLASTIC DISEASE; MAST CELL; MICROANGIOPATHY; NEOVASCULARIZATION (PATHOLOGY); OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE REGENERATION; VASA VASORUM;

ANGIOGENESIS INHIBITORS; CALCINOSIS; CORONARY STENOSIS; DISEASE PROGRESSION; HEMORRHAGE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RUPTURE; VASA VASORUM;

EID: 73649086265     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.11.001     Document Type: Editorial

References (24)

1. Koester W. Endarteritis and arteritis. Berl Klin Wochenschr 13 (1876) 454-455
2. Barger A.C., Beeuwkes III R., Lainey L.L., and Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310 (1984) 175-177
3. Geiringer E. Intimal vascularization and atherosclerosis. J Pathol Bacteriol 63 (1951) 201-211
4. Sluimer J.C., Gasc J.M., van Wanroij J.L., et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 51 (2008) 1258-1265
5. Dunmore B.J., McCarthy M.J., Naylor A.R., and Brindle N.P. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg 45 (2007) 155-159
6. Sluimer J.C., Kolodgie F.D., Bijnens A.P., et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 53 (2009) 1517-1527
7. Moreno P.R., Purushothaman K.R., Sirol M., Levy A.P., and Fuster V. Neovascularization in human atherosclerosis. Circulation 113 (2006) 2245-2252
8. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., and Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93 (1996) 672-682
9. Kaartinen M., Penttila A., and Kovanen P.T. Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. Atherosclerosis 123 (1996) 123-131
10. Gössl M., Versari D., Hildebrandt H.A., et al. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. J Am Coll Cardiol Img 3 (2010) 32-40
11. Kolodgie F.D., Gold H.K., Burke A.P., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003) 2316-2325
12. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25 (2005) 2054-2061
13. Eggen D.A., Strong J.P., and McGill Jr. H.C. Coronary calcification. Relationship to clinically significant coronary lesions and race, sex, and topographic distribution. Circulation 32 (1965) 948-955
14. Raggi P., Callister T.Q., Cooil B., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101 (2000) 850-855
15. Kolodgie F.D., Burke A.P., Farb A., et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 16 (2001) 285-292
16. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
17. Suarez S., and Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 114 (2001) 1229-1235
18. Greenberg J.I., Shields D.J., Barillas S.G., et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456 (2008) 809-813
19. Pilarczyk K., Sattler K.J., Galili O., et al. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 196 (2008) 333-340
20. Post S., Peeters W., Busser E., et al. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 45 (2008) 244-250
21. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
22. Jain R.K., Finn A.V., Kolodgie F.D., Gold H.K., and Virmani R. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med 4 (2007) 491-502
23. Fischer C., Jonckx B., Mazzone M., et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131 (2007) 463-475
24. Jain R.K. A new target for tumor therapy. N Engl J Med 360 (2009) 2669-2671